Inverse Association of Circulating SIRT1 and Adiposity: A Study on Underweight, Normal Weight, and Obese Patients

Autor: Stefania Mariani, Maria R. di Giorgio, Paolo Martini, Agnese Persichetti, Giuseppe Barbaro, Sabrina Basciani, Savina Contini, Eleonora Poggiogalle, Antonio Sarnicola, Alfredo Genco, Carla Lubrano, Aldo Rosano, Lorenzo M. Donini, Andrea Lenzi, Lucio Gnessi

Publikováno v: Frontiers in Endocrinology, Vol 9 (2018)

Context: Sirtuins (SIRTs) are NAD+-dependent deacetylases, cellular sensors to detect energy availability, and modulate metabolic processes. SIRT1, the most studied family member, influences a number of tissues including adipose tissue. Expression an

Externí odkaz: https://doaj.org/article/91df04edb0c042558e106e651e3eb4da

Obesity is associated with lack of inhibitory control and impaired heart rate variability reactivity and recovery in response to food stimuli

Autor: Gabriella Antonucci, Antonio Sarnicola, Anna Maria Petta, Pietro Zingaretti, Cristina Ottaviani, Grazia Fernanda Spitoni, Massimiliano Aragona

Publikováno v: International journal of psychophysiology : official journal of the International Organization of Psychophysiology. 116

Recent theories compare obesity with addiction in terms of lack of inhibitory control in both clinical populations. The present study hypothesized impaired inhibition in obese patients reflected both in executive functions and reduced vagal tone (ind

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c437439c0c1bac6dfc2c18e89330fc9e
https://pubmed.ncbi.nlm.nih.gov/28390903

Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia

Autor: Paola Colombo, Luisa Ciammella, Giancarlo Giupponi, Francesco Barale, Luigi Grassi, Giorgio Di Lorenzo, Maria Frova, Michela Nosè, Gualtiero Guerrini, Liliana Cascone, Francesco Pontarollo, Rodolfo Tomasi, Alfredo Bisogno, Francesca Sartore, Guglielmo Occhionero, Claudio Santilli, Andrea Giambartolomei, Tiziana Sciarma, Marco Menchetti, Matteo Rossattini, Giuseppe Saraò, Farida Ferrato, Gabriele Cipresso, Alessandra Marsilio, Simone Accordini, Anna Maria Pacilli, Francesco Laddomada, Marianna Boso, Giuseppe Migliorini, Lara Malvini, Camilla Lintas, Antonio Ferro, Alessia Cicolini, Luciana Rillosi, Annamarie Tasser, Alberto Siracusano, Mauro Percudani, Roberto Quartesan, Nicoletta Fragomeno, Nicola Garzotto, Flavio Nosè, Corrado Barbui, Raffaella Bivi, Antonio Mautone, Rossella Beneduce, Gerardo Bertolazzi, Andrea Cipriani, Eleonora Esposito, Alberto Bozzani, Stylianos Nicholau, Barbara Dal Santo, Antonio Veronese, Gino Targa, Rossana Travaglini, Ermanna Lazzarin, Francesco Gardellin, Luigi Ferrannini, Stefania Roma, Giuseppe Rossi, Giovanni Rossi, Alessandra Sala, Bruno Biancosino, Massimo Carlo Mauri, Simona Ziero, Domenico Berardi, Roger Pycha, Walter Di Munzio, Serena Mulè, Michele De Francesco, Filippo Bogetto, Arcadio Erlicher, Carlo Piazza, Francesco Risso, Stefania Strizzolo, Marcello Casale, Vincenzo Fricchione Parise, Lorella Grecu, Silvio Scarone, Paola Artioli, Giuseppe Ducci, Raffella Rizzo, Michele Tansella, Natalia Grazian, Livio Marchiaro, Daniele Moretti, Marco Mollica, Paola Rocca, Piera Bucolo, Antonio Sarnicola, Stefania Pecchioli, Ennio Piantato, Francesca Malchiodi

Publikováno v: Trials, Vol 10, Iss 1, p 31 (2009)
Trials

Background One third to two thirds of people with schizophrenia have persistent psychotic symptoms despite clozapine treatment. Under real-world circumstances, the need to provide effective therapeutic interventions to patients who do not have an opt

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dae9b20128aad6473e852d658350a54d
http://hdl.handle.net/11562/337907